A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

The potential market for the drugs is massive — more than 40 percent of adults in the U.S. are obese — and has seen explosive ...

Beyond treating diabetes and helping people lose weight, GLP-1s may also improve libido. But the reasons are as complex as ...

Symptoms of NAION can include blurred vision, peripheral vision loss, dark spots in vision, and changes in color perception. Though the exact mechanism is not fully understood, researchers hypothesize ...

Dr. Sue Mitchell is an experienced gastroenterologist with a background in functional medicine, internal medicine and ...

Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with ...

Tirzepatide, found in Mounjaro and Zepbound, mimics both GIP and GLP-1 hormones to activate insulin production. Semaglutide, ...

A study finds GLP-1 weight-loss drugs may pose vision risks, revealing an unexpected medical irony. A paradoxical insight: ...

Zero Doubt Club, a Northeast Ohio-based wellness center, has introduced a GLP-1 weight-loss program that combines medical ...

Free Press columnist Carlos Monarrez answers three questions about the Lions’ 45-31 divisional-round playoff loss to the Washington Commanders on Saturday at Ford Field. It would be easy to ...

What’s the most effective way to lose weight? If you immediately thought “diet and exercise,” you’re not far off. But according to a new weight loss survey from Everyday Health ...